NCT05284565 is a NA clinical trial of Reading of the skin prick allergy test in Allergy, sponsored by INNOPRICK SL.

Who is sponsoring NCT05284565?

NCT05284565 is sponsored by INNOPRICK SL.

What drugs are being tested in NCT05284565?

Interventions in NCT05284565: Reading of the skin prick allergy test.

Is NCT05284565 still recruiting?

NCT05284565 is currently completed. Last updated 24 April 2023.

Last reviewed 2023-04-24 · How we verify

NCT05284565

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparative Study of Skin Prick Allergy Test Measurements Between Current Manual Procedure and Nexkin DSPT Device

Completed NA Last updated 24 April 2023

What this trial tests

NA trial testing Reading of the skin prick allergy test in Allergy in 93 participants. Completed in 27 July 2021.

Timeline

20 May 2021

Primary endpoint
27 July 2021

27 July 2021

Quick facts

Lead sponsor	INNOPRICK SL
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	93
Start date	20 May 2021
Primary completion	27 July 2021
Estimated completion	27 July 2021
Sites	1 location across Spain

Drugs / interventions tested

Reading of the skin prick allergy test

Conditions studied

Allergy — all drugs for Allergy →

Sponsor

INNOPRICK SL

Who can join

12 and older, any sex, with Allergy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Clinical trial with the aim to evaluate the level of agreement in wheal size measures in allergy skin prick testing (SPT) between the electro-medical device Nexkin DSPT® and the manual measurement procedure used in the daily practice.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Reliability of a novel electro-medical device for wheal size measurement in allergy skin testing: An exploratory clinical trial.
Morales-Palacios MP, Núñez-Córdoba JM, Tejero E, Matellanes Ó, et al · · 2023 · cited 4× · PMID 35950712 · DOI 10.1111/all.15474

Verify or expand the search:

Other recruiting trials for Allergy

Currently open trials in the same condition.

NCT05997784 — Study of Indoor Air Pollutants and Their Impact in Childhood Health and Wellbeing · active not recruiting
NCT06390878 — Nationwide Research on the Rewilding of Kindergarten Yards · NA · recruiting
NCT06248957 — SYSTEMS-LEVEL ANALYSES OF IMMUNE DYSREGULATION · recruiting
NCT05449756 — A Follow-up Study With Children Who Participated in the TEMPO Study in Their First Year of Life · recruiting
NCT06192914 — EPAP, Interviewstudy · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05284565 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by INNOPRICK SL
Last refreshed: 24 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05284565.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing